Signature »

Eliem Therapeutics shares owned by Signature

Quarter-by-quarter ownership of Eliem Therapeutics (CLYM) shares owned by Signature from 13F filings

Historical chart of Signature investment in Eliem Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eliem Therapeutics held by Signature consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eliem Therapeutics by Signature

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.7k 333 5.09

More positions owned by Signature

Ishares Tr Rus 1000 Grw Etf (IWF)
Ishares Tr Core S&p Us Vlu (IUSV)
Vanguard Specialized Funds Div App Etf (VIG)
J P Morgan Exchange Traded F Us Qualty Fctr (JQUA)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Index Fds Small Cp Etf (VB)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Tr National Mun Etf (MUB)
Apple (AAPL)
Vanguard Index Fds Large Cap Etf (VV)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Vanguard Index Fds Growth Etf (VUG)

View all positions for Signature

Top funds holding Eliem Therapeutics

RA Capital Management
Samsara BioCapital
Boxer Capital
BlackRock
Affinity Asset Advisors
T. Rowe Price Associates
Geode Capital Management
Driehaus Capital Management
Point72 Asset Management
Nan Fung Group Holdings
Northern Trust
Dr. Jeffrey R. Jay, M.D.
Monashee Investment Management
Ikarian Capital
TD Asset Management

View all funds holding Eliem Therapeutics